Skip to main content
logo
Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.560
0.00 (0.00%)
At close: Jun 12, 2026, 4:00 PM EDT
1.610
+0.050 (3.21%)
Pre-market: Jun 15, 2026, 7:29 AM EDT

Autolus Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
130.93--239.57382.44310.34
Short-Term Investments
98.51-----
Cash & Short-Term Investments
229.43--239.57382.44310.34
Cash Growth
-55.59%---37.36%23.23%102.44%
Accounts Receivable
27.66-----
Inventory
33.23-----
Other Current Assets
78.51--35.7443.3436.61
Total Current Assets
368.84--275.3425.77346.95
Net Property, Plant & Equipment
134.47--95.6558.4252.32
Other Intangible Assets
18.98----0.07
Other Long-Term Assets
4.78--4.436.086.23
Total Assets
527.07--375.38490.27405.56
Accounts Payable
1.87--0.10.530.43
Accrued Expenses
46.77--39.5840.823.67
Current Portion of Leases
3.06--5.055.044.45
Other Current Liabilities
11.9-----
Total Current Liabilities
63.6--44.7446.3728.55
Long-Term Leases
76.9--47.9119.2216.55
Other Long-Term Liabilities
277.75--171.26126.0247.14
Total Long-Term Liabilities
354.64--219.17145.2363.69
Total Liabilities
418.24--263.91191.692.24
Common Stock
0.13--0.130.130.12
Additional Paid-in Capital
1,574--1,0191,008843.11
Accumulated Other Comprehensive Income
-6.63---28.99-38.9-8.57
Retained Earnings
-1,458---878.56-670.18-521.34
Shareholders' Equity
108.83--111.47298.67313.32
Total Liabilities & Equity
527.07--375.38490.27405.56
Total Debt
79.960052.9724.2621
Net Cash (Debt)
149.48-0-0186.6358.18289.34
Net Cash Growth
----47.90%23.79%191.86%
Net Cash Per Share
0.56--1.073.774.01
Book Value
108.8300111.47298.67313.32
Book Value Per Share
0.41--0.643.144.35
Tangible Book Value
89.8500111.47298.67313.26
Tangible Book Value Per Share
0.34--0.643.144.35
SEC Filings: 10-K · 10-Q